nach oben

Erschienen in:

15.12.2018 | Clinical Management of Endocrine Diseases

Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome

verfasst von: Anna Maria Formenti, Mauro Doga, Stefano Frara, Marco Ritelli, Marina Colombi, Giuseppe Banfi, Andrea Giustina

Erschienen in: Endocrine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Ehlers–Danlos syndrome (EDS) is an emerging cause of skeletal fragility. Mechanism of bone damage are probably multifactorial in line with the different skeletal phenotypes that can be found in clinical practice. A structured approach to clinical management of bone metabolic complication in EDS is proposed.

B. Steinmann, P.M. Royce, A. Superti-Furga, in: Connective Tissue and Its Heritable Disorders, ed. by P.M. Royce, B. Steinmann (Wiley-Liss: New York, NY, USA, 2002), pp. 431–524

F. Malfait, C. Francomano, P. Byers, J. Belmont, B. Berglund et al. The 2017 international classification of the Ehlers–Danlos syndromes. Am. J. Med. Genet. 175C, 8–26 (2017)CrossRef

M. Colombi, C. Dordoni, N. Chiarelli, M. Ritelli, Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am. J. Med. Genet. 169, 6–22 (2015)CrossRef

M. Ritelli, M. Venturini, C. Dordoni, N. Chiarelli, S. Quinzani et al. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. Orphanet. J. Rare. Dis. 8, 58 (2013)CrossRefPubMedPubMedCentral

M. Colombi, C. Dordoni, M. Venturini, C. Ciaccio, S. Morlino et al. Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers-Danlos syndrome patients. Clin. Genet. 92, 624–631 (2017)CrossRefPubMed

M. Castori, B. Tinkle, H. Levy, R. Grahame, F. Malfait, A. Hakim, A framework for the classification of joint hypermobility and related conditions. A continuous spectrum of phenotypes exists grouping together patients with isolated, non-syndromic joint hypermobility, HSD and hEDS. Am. J. Med. Genet. C. Semin. Med. Genet. 175(1), 148–157 (2017)CrossRefPubMed

M. Castori, A. Hakim, Contemporary approach to joint hypermobility and related disorders. Curr. Opin. Pediatr. 29(6), 640–649 (2017)CrossRefPubMed

Y. Gazit, G. Jacob, R. Grahame, Ehlers–Danlos syndrome—hypermobility type: a much neglected multisystemic disorder. Rambam Maimonides Med 7, 1–10 (2016)

A.A. Deodhar, A.D. Woolf, Ehlers-Danlos syndrome and osteoporosis. Ann. Rheum. Dis. 53, 841–842 (1994)CrossRefPubMedPubMedCentral

10.

P.C. Coelho, R. Santos, J.A. Gomes, Osteoporosis and Ehlers-Danlos syndrome. Ann. Rheum. Dis. 53, 212–213 (1994)CrossRefPubMedPubMedCentral

11.

A.L. Dolan, N.K. Arden, R. Grahame, T.D. Spector, Assessment of bone in Ehlers Danlos syndrome by ultrasound and densitometry. Ann. Rheum. Dis. 57, 630–633 (1998)CrossRefPubMedPubMedCentral

12.

G. Mazziotti, C. Dordoni, M. Doga, F. Galderisi et al. High prevalence of radiological vertebral fractures in adult patients with Ehlers–Danlos syndrome. Bone 84, 88–92 (2016)CrossRefPubMed

13.

C. Eller-Vainicher, A. Bassotti, A. Imeraj, E. Cairoli et al. Bone involvement in adult patients affected with Ehlers-Danlos syndrome. Osteoporos. Int. 27, 2525–2531 (2016)CrossRefPubMed

14.

S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi et al. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 30, 1837–1844 (2005)CrossRef

15.

G. Mazziotti, M. Doga, S. Frara, F. Maffezzoni et al. Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine 52, 103–110 (2016)CrossRefPubMed

16.

G. Mazziotti, A. Delgado, F. Maffezzoni, A. Formenti et al. Skeletal fragility in endogenous hypercortisolism. Front. Horm. Res. 46, 66–73 (2016)CrossRefPubMed

17.

P. Beighton, A. De Paepe, B. Steinmann, P. Tsipouras et al. Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am. J. Med. Genet. 77, 31–37 (1998)CrossRefPubMed

18.

J.T. Schousboe, J.A. Shepherd, J.P. Bilezikian et al. Executive summary of the2013 International Society for Clinical Densitometry position development conference on bone densitometry. J. Clin. Densitom. 16, 455–466 (2013)CrossRefPubMed

19.

J.F. Griffith, H.K. Genant, New advances in imaging osteoporosis and its complications. Endocrine 42, 39–51 (2012)CrossRefPubMed

20.

R.T. Franceschi, The developmental control of osteoblast specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit. Rev. Oral. Biol. Med. 10, 40–57 (1999)CrossRefPubMed

21.

C. Ge, Q. Yang, G. Zhao, H. Yu et al. Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J. Bone Miner. Res. 27, 538–551 (2012)CrossRefPubMedPubMedCentral

22.

G.S. Schultz, J.M. Davidson, R.S. Kirsner, P. Bornstein et al. Dynamic reciprocity in the wound microenvironment. Wound Rep. Reg. 19, 134–148 (2011)CrossRef

23.

T. Palomo, T. Vilaça, M. Lazaretti-Castro, Osteogenesis imperfecta: diagnosis and treatment. Curr. Opin. Endocrinol. Diabetes Obes. 24, 381–388 (2017)CrossRefPubMed

24.

M. Fiscaletti, C.P. Coorey, A. Biggin, J. Briody, Diagnosis of recurrent fractures in a pediatric cohort. Calcif. Tissue Int. 103(5), 529–539 (2018). https://doi.org/10.1007/s00223-018-0449-6 CrossRefPubMed

25.

J. Lim, I. Grafe, S. Alexander, B. Lee, Genetic causes and mechanisms of osteogenesis imperfecta. Bone 102, 40–49 (2017)CrossRefPubMedPubMedCentral

26.

N. Chiarelli, G. Carini, N. Zoppi, C. Dordoni, M. Ritelli, M. Venturini, M. Castori, M. Colombi, Transcriptome-wide expression profiling in skin fibroblasts of patients with joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type. PLoS ONE 11(8), e0161347 (2016)CrossRefPubMedPubMedCentral

27.

N. Zoppi, N. Chiarelli, S. Binetti, M. Ritelli, M. Colombi, Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders. Biochem Biophys. Acta 1864(4 Pt A), 1010–1023 (2018)

28.

S. Shuster, Osteoporosis, a unitary hypothesis of collagen loss in skin and bone. Med. Hypotheses 65, 426–432 (2005)CrossRefPubMed

29.

L. Carbone, F.A. Tylavsky, A.J. Bush, W. Koo et al. Bone density in Ehlers–Danlos syndrome. Osteoporos. Int. 11, 388–392 (2000)CrossRefPubMed

30.

M.F. Holick, A. Hossein-Nezhad, F. Tabatabaei, Multiple fractures in infants who have Ehlers–Danlos/hypermobility syndrome and or vitamin D deficiency: a case series of 72 infants whose parents were accused of child abuse and neglect. Dermatoendocrinol 9(1), e1279768 (2017). https://doi.org/10.1080/19381980.2017.1279768 CrossRefPubMedPubMedCentral

31.

M. Yamashita, K. Hasegawa, Y. Higuchi, T. Miyai et al. Urinary cross-linked N-terminal telopeptide of type I collagen levels of infants with Osteogenesis Imperfecta and healthy infants. Acta Med. Okayama 70, 435–439 (2016)PubMed

32.

E. Aström, P. Magusson, S. Eksborg, S. Söderhäll, Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with Osteogenesis Imperfecta. Acta Paediatr. 99, 1834–1840 (2010)CrossRefPubMed

33.

G. Mazziotti, A.M. Formenti, S. Frara, R. Olivetti et al. High prevalence of radiological vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma. J. Clin. Endocrinol. Metab. 103, 956–964 (2017)CrossRef

34.

D. Diacinti, D. Pisani, M. D”Avanzo, M. Celli et al. Reliability of vertebral fractures assessment (VFA) in children with Osteogenesis Imperfecta. Calcif. Tissue 96, 307–312 (2015)CrossRef

35.

C. Grey, R. Young, P.W. Bearcroft, J.E. Compston, Vertebral deformity in the thoracic spine in post-menopausal women: value of lumbar spine bone density. Br. J. Radiol. 69, 137–42 (1996)CrossRefPubMed

36.

G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58–69 (2012)CrossRefPubMed

37.

G. Mazziotti, S. Frara, A. Giustina, Pituitary diseases and bone. Endocr. Rev. 39, 440–488 (2018). https://doi.org/10.1210/err.2018-00005 CrossRefPubMed

Titel: Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome
verfasst von: Anna Maria Formenti
Mauro Doga
Stefano Frara
Marco Ritelli
Marina Colombi
Giuseppe Banfi
Andrea Giustina
Publikationsdatum: 15.12.2018
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1822-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas

Long-term sequelae of the less than total thyroidectomy procedures for benign thyroid nodular disease

Adrenal myelolipoma in association with congenital adrenal hyperplasia

The co-activator-associated arginine methyltransferase 1 (CARM1) gene is overexpressed in type 2 diabetes

Increased frequency of impaired fasting glucose and isolated systolic hypertension in Paget’s disease of bone

Intraoperative unfolding and postoperative pruning of the pituitary gland after transsphenoidal surgery for pituitary adenoma: A volumetric and endocrinological evaluation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin